Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Financing Cash Flow
-$121.10M
TTM · Period ending: · USD
BIO Financing Cash Flow
Latest reported-$121.10Mperiod ending
Latest reported-$121.10Mperiod ending
BIO TTM Cash from Financing ($7.40M → -$121.10M)
TTM financing cash flow
High-resolution chart · PNG
BIO financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -47,474,000 | |
| -49,381,000 | |
| -41,606,000 | |
| 154,399,000 | |
| 185,670,000 | |
| 192,190,000 | |
| 182,300,000 | |
| -11,200,000 | |
| -14,900,000 | |
| -9,900,000 | |
| -900,000 | |
| 39,200,000 | |
| 46,800,000 | |
| 36,500,000 | |
| 33,500,000 | |
| -24,200,000 | |
| -21,400,000 | |
| -17,000,000 | |
| -25,200,000 | |
| -10,800,000 | |
| -14,800,000 | |
| -16,000,000 | |
| -13,100,000 | |
| -16,500,000 | |
| -18,400,000 | |
| -24,700,000 | |
| -32,900,000 | |
| -44,000,000 | |
| -44,400,000 | |
| -26,200,000 | |
| -15,200,000 | |
| 11,200,000 | |
| -600,000 | |
| 1,100,000 | |
| 1,700,000 | |
| -2,200,000 | |
| 26,800,000 | |
| 20,500,000 | |
| 25,400,000 | |
| 25,500,000 | |
| 13,000,000 | |
| 13,800,000 | |
| 7,400,000 | |
| 3,200,000 | |
| 3,700,000 |